Loading...
Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway
Norcantharidin (NCTD) is an efficacious anti-cancer drug that has been used in China for many years, but its underlying mechanism of action is still not fully understood. In the present study, we found that NCTD could induce morphological changes in colon cancer cells, causing a transition from a sp...
Saved in:
Published in: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Nature Publishing Group
2016
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4742802/ https://ncbi.nlm.nih.gov/pubmed/26846153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep20500 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|